Abobotulinum - a toxin injection in patients with refractory idiopathic detrusor overactivity: injections in detrusor, trigone and bladder neck or prostatic urethra, versus detrusor - only injections

Abobotulinum - a toxin injection in patients with refractory idiopathic detrusor overactivity: injections in detrusor, trigone and bladder neck or prostatic urethra, versus detrusor - only injections

ABSTRACT Purpose: To evaluate if the injections of abobotulinum-A toxin in trigone and bladder neck/prostatic urethra in addition to detrusor provides better symptoms relief and urodynamic findings in patients with idiopathic detrusor overactivity (IDO) refractory to medical treatment. Materials and Methods: A total of 74 patients with IDO refractory to anticholinergics received injections in detrusor, trigone and bladder neck/prostatic urethra (Group A, N=36) versus detrusor only injections (Group B, N=38) of abobotulinum-A toxin. All patients were evaluated by a standard overactive bladder symptom score (OABSS) questionnaire and cystometrography before and 6 weeks after the operation. OABSS questionnaire was also completed 20 weeks after the operation. Results: The magnitude of OABSS reduction from baseline to 6 weeks after operation in groups A and B patients was 13.4±2.2 versus 11.7±2.1 (p=0.001). Cystometry results were similar in both groups except for higher volume at urgent desire to void in Group B patients (p <0.001). The mean±SD change in residual volume in Group A at 6 weeks after the operation was −4.8±28.6mL (p=0.33) compared to 21.3±16.9mL in Group B patients (p <0.001). Conclusions: In patients with IDO, adding trigone, and bladder neck/prostatic urethra as sites of abobotulinum- A toxin injection produces greater reductions in OABSS score and less residual urine volume but a lower volume at urgent desire to void in comparison with detrusor only injections.

Saved in:
Bibliographic Details
Main Authors: Emami,Maryam, Shadpour,Pejman, Kashi,Amir H., Choopani,Masoud, Zeighami,Mohammadreza
Format: Digital revista
Language:English
Published: Sociedade Brasileira de Urologia 2017
Online Access:http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1677-55382017000601122
Tags: Add Tag
No Tags, Be the first to tag this record!
id oai:scielo:S1677-55382017000601122
record_format ojs
spelling oai:scielo:S1677-553820170006011222017-12-19Abobotulinum - a toxin injection in patients with refractory idiopathic detrusor overactivity: injections in detrusor, trigone and bladder neck or prostatic urethra, versus detrusor - only injectionsEmami,MaryamShadpour,PejmanKashi,Amir H.Choopani,MasoudZeighami,Mohammadreza Urinary Bladder Overactive Botulinum Toxins ABSTRACT Purpose: To evaluate if the injections of abobotulinum-A toxin in trigone and bladder neck/prostatic urethra in addition to detrusor provides better symptoms relief and urodynamic findings in patients with idiopathic detrusor overactivity (IDO) refractory to medical treatment. Materials and Methods: A total of 74 patients with IDO refractory to anticholinergics received injections in detrusor, trigone and bladder neck/prostatic urethra (Group A, N=36) versus detrusor only injections (Group B, N=38) of abobotulinum-A toxin. All patients were evaluated by a standard overactive bladder symptom score (OABSS) questionnaire and cystometrography before and 6 weeks after the operation. OABSS questionnaire was also completed 20 weeks after the operation. Results: The magnitude of OABSS reduction from baseline to 6 weeks after operation in groups A and B patients was 13.4±2.2 versus 11.7±2.1 (p=0.001). Cystometry results were similar in both groups except for higher volume at urgent desire to void in Group B patients (p <0.001). The mean±SD change in residual volume in Group A at 6 weeks after the operation was −4.8±28.6mL (p=0.33) compared to 21.3±16.9mL in Group B patients (p <0.001). Conclusions: In patients with IDO, adding trigone, and bladder neck/prostatic urethra as sites of abobotulinum- A toxin injection produces greater reductions in OABSS score and less residual urine volume but a lower volume at urgent desire to void in comparison with detrusor only injections.info:eu-repo/semantics/openAccessSociedade Brasileira de UrologiaInternational braz j urol v.43 n.6 20172017-12-01info:eu-repo/semantics/articletext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S1677-55382017000601122en10.1590/s1677-5538.ibju.2016.0622
institution SCIELO
collection OJS
country Brasil
countrycode BR
component Revista
access En linea
databasecode rev-scielo-br
tag revista
region America del Sur
libraryname SciELO
language English
format Digital
author Emami,Maryam
Shadpour,Pejman
Kashi,Amir H.
Choopani,Masoud
Zeighami,Mohammadreza
spellingShingle Emami,Maryam
Shadpour,Pejman
Kashi,Amir H.
Choopani,Masoud
Zeighami,Mohammadreza
Abobotulinum - a toxin injection in patients with refractory idiopathic detrusor overactivity: injections in detrusor, trigone and bladder neck or prostatic urethra, versus detrusor - only injections
author_facet Emami,Maryam
Shadpour,Pejman
Kashi,Amir H.
Choopani,Masoud
Zeighami,Mohammadreza
author_sort Emami,Maryam
title Abobotulinum - a toxin injection in patients with refractory idiopathic detrusor overactivity: injections in detrusor, trigone and bladder neck or prostatic urethra, versus detrusor - only injections
title_short Abobotulinum - a toxin injection in patients with refractory idiopathic detrusor overactivity: injections in detrusor, trigone and bladder neck or prostatic urethra, versus detrusor - only injections
title_full Abobotulinum - a toxin injection in patients with refractory idiopathic detrusor overactivity: injections in detrusor, trigone and bladder neck or prostatic urethra, versus detrusor - only injections
title_fullStr Abobotulinum - a toxin injection in patients with refractory idiopathic detrusor overactivity: injections in detrusor, trigone and bladder neck or prostatic urethra, versus detrusor - only injections
title_full_unstemmed Abobotulinum - a toxin injection in patients with refractory idiopathic detrusor overactivity: injections in detrusor, trigone and bladder neck or prostatic urethra, versus detrusor - only injections
title_sort abobotulinum - a toxin injection in patients with refractory idiopathic detrusor overactivity: injections in detrusor, trigone and bladder neck or prostatic urethra, versus detrusor - only injections
description ABSTRACT Purpose: To evaluate if the injections of abobotulinum-A toxin in trigone and bladder neck/prostatic urethra in addition to detrusor provides better symptoms relief and urodynamic findings in patients with idiopathic detrusor overactivity (IDO) refractory to medical treatment. Materials and Methods: A total of 74 patients with IDO refractory to anticholinergics received injections in detrusor, trigone and bladder neck/prostatic urethra (Group A, N=36) versus detrusor only injections (Group B, N=38) of abobotulinum-A toxin. All patients were evaluated by a standard overactive bladder symptom score (OABSS) questionnaire and cystometrography before and 6 weeks after the operation. OABSS questionnaire was also completed 20 weeks after the operation. Results: The magnitude of OABSS reduction from baseline to 6 weeks after operation in groups A and B patients was 13.4±2.2 versus 11.7±2.1 (p=0.001). Cystometry results were similar in both groups except for higher volume at urgent desire to void in Group B patients (p <0.001). The mean±SD change in residual volume in Group A at 6 weeks after the operation was −4.8±28.6mL (p=0.33) compared to 21.3±16.9mL in Group B patients (p <0.001). Conclusions: In patients with IDO, adding trigone, and bladder neck/prostatic urethra as sites of abobotulinum- A toxin injection produces greater reductions in OABSS score and less residual urine volume but a lower volume at urgent desire to void in comparison with detrusor only injections.
publisher Sociedade Brasileira de Urologia
publishDate 2017
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1677-55382017000601122
work_keys_str_mv AT emamimaryam abobotulinumatoxininjectioninpatientswithrefractoryidiopathicdetrusoroveractivityinjectionsindetrusortrigoneandbladderneckorprostaticurethraversusdetrusoronlyinjections
AT shadpourpejman abobotulinumatoxininjectioninpatientswithrefractoryidiopathicdetrusoroveractivityinjectionsindetrusortrigoneandbladderneckorprostaticurethraversusdetrusoronlyinjections
AT kashiamirh abobotulinumatoxininjectioninpatientswithrefractoryidiopathicdetrusoroveractivityinjectionsindetrusortrigoneandbladderneckorprostaticurethraversusdetrusoronlyinjections
AT choopanimasoud abobotulinumatoxininjectioninpatientswithrefractoryidiopathicdetrusoroveractivityinjectionsindetrusortrigoneandbladderneckorprostaticurethraversusdetrusoronlyinjections
AT zeighamimohammadreza abobotulinumatoxininjectioninpatientswithrefractoryidiopathicdetrusoroveractivityinjectionsindetrusortrigoneandbladderneckorprostaticurethraversusdetrusoronlyinjections
_version_ 1756428241889918976

Similar Items